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Alix/AIP1 regulates cell death in a way
involving interactions with the calcium
binding protein ALG-2 and with proteins of
the endosomal sorting complex required for
transport (ESCRT). Using mass
spectrometry we identified caspase-8
among proteins co-immunoprecipitating
with Alix in dying neurons. We next
demonstrated that Alix and ALG-2 interact
with pro-caspase-8, and that Alix forms a
complex with the TNF receptor-1 (TNF-
R1), depending on its capacity to bind
ESCRT proteins. Thus, Alix and ALG-2
may allow the recruitment of pro-caspase-8
onto endosomes containing TNF-R1, a step
thought to be necessary for activation of the
apical caspase. In line with this, expression
of Alix deleted of its ALG-2 binding site
(AlixALG-2) significantly reduced TNF-
R1 induced cell death, without affecting
endocytosis of the receptor. In a more
physiological setting, we found that
programmed cell death of motoneurons,
which can be inhibited by AlixALG-2, is
regulated by TNF-R1. Taken together,
these results define Alix and ALG-2 as
regulators of the TNF-R1 cell death
pathway.
Endocytosis of cell surface receptors has
long been described as an effective way of
switching off extracellularly induced signals.
Endocytosed activated receptors traffic
through early endosomes and are sorted into
intralumenal vesicles accumulating inside
endosomes known as multivesicular bodies
(MVBs). These MVBs fuse with lysosomes
where the receptors meet their end by acid
hydrolysis (1).
In some cases however, such as for
neurotrophin bound Trk receptors, activated
receptors continue signalling inside
endosomes (2). Also, in the case of death
receptors, Schütze and colleagues showed that
endocytosis of TNF-R1, which occurs after
binding to TNF, is a necessary step for
activation of caspases and consequently
apoptosis. They found that the apical pro-
caspase-8 is recruited and thereby activated on
the surface of multivesicular endosomes
containing activated TNF-R1 (3).
Biogenesis of MVBs is under tight control
by a set of proteins, making the so-called
endosomal sorting complexes required for
transport (ESCRT-0 to -III), which
sequentially associate on the cytosolic surface
of endosomes (4). A partner of ESCRT
proteins, which also regulates the making of
MVBs, is the protein Alix/AIP1, first
characterised as an interactor of the calcium
binding protein ALG-2 (Apoptosis Linked
Gene-2) (5-7). Enveloped viruses, like HIV-1,
use Alix to recruit the ESCRT machinery in
order to deform membranes and allow fission
during viral budding (8,9). Furthermore, two
recent reports have claimed that Alix together
with ESCRT proteins might also be involved
in the abscission stage of cytokinesis (10,11).
Besides Tsg101 and CHMP-4B of ESCRT-I
and III respectively, Alix interacts with
lysobisphosphatidic acid (LBPA), a
phospholipid involved in intralumenal
vesiculation of endosomes (12), and with
regulators of endocytosis (CIN85 and
2endophilins) (13,14). However, the precise
role of Alix on endosomes remains largely
unclear as neither we nor other laboratories
have found any striking effect of Alix on
endocytosis and degradation of EGF or
transferrin receptors (15,16).
Alix may play a role in cell death. In
particular, expression of a mutant lacking the
N-terminal part (Alix-CT) blocks death of
Hela cells induced by serum starvation (7) and
of cerebellar neurons deprived of potassium
(17). In this latter paradigm, Alix-CT whose
protecting activity was strictly correlated with
its capacity to bind ALG-2, accumulated
inside cytoplasmic aggregates together with
ALG-2 and caspases. We also demonstrated,
using electroporation in the chick embryo, that
Alix mutants block programmed cell death of
motoneurons during normal development,
depending on binding to ALG-2, ESCRT-I
and III. Our interpretation of these results is
that some truncated forms of Alix behave as
dominant negative mutants blocking the
formation of an ALG-2/Alix/ESCRT complex
necessary for cell death (18). Therefore the
Alix/ALG-2 complex could make a link
between endosomes and a signalling- or an
execution step of neuronal death (19).
We have undertaken the present study to
characterise this link and found that Alix and
ALG-2 form a complex with endocytosed
TNF-R1 and pro-caspase-8. Testing the
physiological significance of these interactions
both in vivo and in vitro allowed us to define




Human recombinant TNF-Flag was from
Alexis biochemicals (Covalab, France).
Mouse monoclonal anti-haemagglutinin (HA)
antibody was from Cell Signaling (Ozyme,
France); polyclonal antibodies against Myc,
TNF-R1 and FADD were from Santa Cruz
Biotechnology (Germany); polyclonal
antibodies against LAMP1 and EEA1 were
from AbCam (France); anti-Flag monoclonal
(M1 and M2) and polyclonal antibodies from
Sigma-Aldrich (France); GM130 and
monoclonal anti-AIP1/Alix was from BD
Transduction (France); anti-ALG-2 was from
Swant (Switzerland); HSP70 mitochondria
was from Affinity Bioreagents (Ozyme,
France); anti-caspase 8 was from Biovision
(Clinisciences, France); horseradish




Laboratories (USA); biotinylated goat anti-
rabbit antibody from Vector Laboratories,
(USA).
DNA constructs
For expression in the chick embryo, human
TNF-R1 (wt or mutants), a catalytically dead
version of human pro-caspase-8 (mutation
C360A), and baculovirus p35 were inserted
into the pCAGGS expression vector (a gift of
Tsuyoshi Momose; Nara Institute of Science
and Technology, Japan). Mammalian
expression vectors coding for DN-caspase-8-
HA-Tagged and p35 were a gift of P.Mehlen
(Inserm Lyon, France). Those coding for wt or
mutated human TNF-R1 were kind gifts from
W. Schneider-Brachert (University of
Regensburg, Germany). Mutated ALG-
2EF
1,3
was a gift of M. Maki (Nagoya
University, Nagoya, Japan).
In ovo electroporation
Fertilised Isa Brown eggs (Société Française
de Production Avicole, St Marcellin, France)
were electroporated at Hamburger Hamilton
(HH) stage 16. Plasmid DNA was
electroporated as described in (18).
Histological analysis
Chick embryos were collected 48h after
electroporation processed and cryo-sectioned
as described previously in (18).
Immuno-histochemistry and –fluorescence
Frozen sections were incubated with
polyclonal anti-TNF-R1 or monoclonal anti-
HA antibodies, diluted to 1/100 in Tris Buffer
Saline containing 1% GS/0.02% saponine
(TBSS) for 12 to 24 hours at 4°C. Sections




biotinylated goat anti-rabbit secondary
antibody, amplified using the ABC kit (Vector
Laboratories, USA) and revealed with 3,3’-
diaminobenzidine (DAB) and nickel
intensification. Sections were rinsed in TBS,
incubated 30 minutes at 37°C in Hoechst
33342, 2 μg/ml (Sigma, France), before
mounting in Mowiol (Calbiochem, France).
Terminal deoxynucleotidyl transferase-
mediated dUTP-biotin nick end labelling
(TUNEL) method
TUNEL analysis were performed using the
In Situ Cell Death Detection kit (Roche,
France). Fluorescent positive cells were
3counted in every third section. Twelve
sections per embryo were counted.
RT-PCR
RNA were extracted from whole chick
embryo using Trizol reagent (Invitrogen).
cDNAs were synthesised with MMLV-RT
(Promega, France) and controlled with
GAPDH. TNF-R1 expression was further
analysed by amplification of a 695 nt fragment
with the following oligonucleotides:
5’GATACTGTGTGTGGCTGT3’and
5’CGTAAATGTCGATGCTCC3’ based on
the chick TNF-R1 homologue (Gallus gallus
accession number AJ720473).
Cell culture and transfection
HEK-293 cells were maintained in DMEM
(Invitrogen, France) containing 10% foetal
bovine serum (FBS) (Invitrogen, France), 2
mM glutamine, 10 g/ml streptamycine and
10 U/ml penicilline. BHK-21 cells were
maintained in G-MEM (Invitrogen) containing
5% FBS, 2.6 g/L tryptose phosphate broth, 2
mM glutamine, 10 g/ml streptamycine and
10 U/ml penicillin. HEK 293 or BHK-21 cells
were transfected using JetPEI (Ozyme,
France).
Alix Knock-down in BHK cells
The Alix shRNA was cloned downstream of
the human H1 promoter in the vector
pSuperGFP (Oligoengine, USA). The
sequences of the synthetic oligonucleotides








Annealed oligonucleotides were ligated into
the BglII cleavage site within the pSuperGFP
vector linearised with the same restriction
enzymes.
BHK cells were transfected with
pSuper/shAlix plasmid or pSuperGFP vector
for control using the JetSi transfection reagent
(Polyplus tranfection, France). Transfected
cells were selected using 800 g/ml of G418.
After 15 days, clones were isolated and
selected for the best reduction in Alix
expression. Cells (pSuper/shAlix and control)
were grown in presence 800 g/ml of G418.
Mass spectrometry and Protein identification
Cultures of mouse cerebellar granule
neurons were prepared as described previously
(Trioulier et al., 2004) and cultured in BME
containing 25 mM potassium. Medium was
changed for BME containing 5 mM potassium
and cells were lysed 4 hours later in RIPA
buffer buffer (150 mM NaCl, 50 mM Tris pH
8.0, 1% NP-40, 0.5% deoxycholate, 0.1% SDS
containing a protease inhibitor mixture
(Roche, France). Immunoprecipitations were
performed using polyclonal-anti-Alix antibody
and protein-G coupled Sepharose beads. After
separation by SDS-PAGE, discrete bands were
excised from the Coomassie blue-stained gel.
In-gel digestion was performed as previously
described (41). Gel pieces were then
sequentially extracted with 5% (vol/vol)
formic acid solution, 50% acetonitrile, 5%
(vol/vol) formic acid, and acetonitrile. After
drying, the tryptic peptides were resuspended
in 0.5% aqueous trifluoroacetic acid. For
MALDI-TOF-MS analyses, a 0.5 L aliquot
of peptide mixture was mixed with 0.5 L
matrix solution (cyano-4-hydroxycinnamic
acid at half saturation in 60 % acetonitrile / 0.1
% trifluoroacetic acid (TFA) (vol/vol)). The
resulting solution was spotted on a MALDI-
TOF target plate, dried and rinsed with 2L of
0.1 % TFA. Peptide mixtures were then
analysed with a MALDI-TOF mass
spectrometer (Autoflex, Bruker Daltonik,
Germany) in reflector/delayed extraction
mode over a mass range of 0-4200 Da. Spectra
were annotated (XMass software) and the
peptide mass fingerprints obtained were
finally submitted to database searches against
the Swissprot Trembl database with an
intranet 1.9 version of MASCOT software.
Immunoprecipitation and Western blotting
Twenty-four hours after transfection, HEK-
293 or BHK-21 were lysed in RIPA. Cell
lysates were cleared by a 14 000 g
centrifugation for 15 min, and incubated
overnight at 4°C with anti-Flag monoclonal
M2 Ab. Immune complexes were precipitated
with protein G-Sepharose (Amersham
Biosciences, France) and the beads washed
with RIPA buffer. Immunoprecipitated
proteins were separated by 10% SDS-PAGE
and transferred onto a PVDF membrane
(Millipore, France). Membranes were blocked
with 5% milk in TBS containing 0.1% Tween
and incubated with the appropriate antibodies.
Bands were revealed using the ECL detection
reagent (Perbio, France).
In the case of immunoprecipitation between
endogenous Alix and TNF-R1, HeLa cells
4were lysed in RIPA buffer. Cell lysates were
cleared by a 14 000 g centrifugation for 15
minutes followed by two incubations of 30
min with protein G-Sepharose beads. Cell
lysates containing 5 mg total proteins were
incubated 1h at 4°C with the polyclonal
antibody against TNF-R1. Immune complexes
were precipitated with protein G-Sepharose
(Amersham Biosciences, France) and the
beads washed with RIPA buffer.
Immunoprecipitated proteins were separated
by 8% SDS-PAGE and treated as described
above. Alix was detected using the
monoclonal anti-AIP1/ Alix from BD
transduction laboratories.
Quantification of cell death induced by TNF-
R1
Twenty hours after transfection, HEK-293
were washed in PBS, pH 7.4 and fixed in 4%
paraformaldehyde for 20 min at 4°C. Cells
were stained with polyclonal anti-TNF-R1
antibody (1/100) and anti-rabbit Alexa
594
antibody (1/500). Cells were rinsed in TBS,
incubated for 30 minutes at 37°C in 2 μg/ml
Hoechst 33342 (Sigma) and mounted in
Mowiol. Cell viability was scored on the basis
of nuclear morphology, condensed or
fragmented nuclei being counted as dead.
In some cases, tetrazolium salt MTT (Sigma,
France) was added to cells at a final
concentration of 1 mg/ml and incubated for
30 min at 37 °C. Dimethyl sulfoxide was used
to dissolve the formazan product and
absorbance was measured in each well at
540 nm, using a measure at 630 nm as
reference, in a Biotek Elx-800 microplate
reader (Mandel Scientific Inc, Canada).
TNF internalisation
BHK cells co-expressing TNF-R1 and the
indicated proteins, were incubated for 1 h at
4°C with 1 ng
125
I-labelled human
recombinant TNF (specific activity 2160
kBq/g) (NEN Life Science Products,
PerkinElmer LAS, France). Cells were then
incubated at 37°C to allow endocytosis for the
indicated times. The amount of intracellular
125
I-TNF receptor complexes formed at 37°C
was estimated after washing cells for 5
minutes in cold acetic acid buffer (200 mM
acetic acid, 500 mM NaCl pH 2.5). After two
washes in PBS, cells were lysed in RIPA
buffer. Total amount of cell-associated
125
I-
TNF was determined on cells, washed only
with PBS, instead of the acetic acid buffer.
The amount of internalised (pH 2.5 resistant)
125
I-TNF was calculated as a percentage of
125
I-TNF bound at pH 7.4.
Magnetic isolation of endosomes containing
TNF-R1 bound to TNF
HEK 293 cells, transfected with TNF-R1 and
Alix-Myc were incubated in a total volume of
1 ml of cold D-PBS (0.9 mM CaCl2, 0.493
mM MgCl2, 2.67 mM KCl, 1.47 mM KH2PO4,
138 mM NaCl, 8 mM Na2HPO4) containing
3% BSA, 100 ng/ml TNF-Flag and 10 g/ml
anti-Flag monoclonal M1 for 1 h at 4°C. They
were then washed twice in cold D-PBS and
incubated for 1 h at 4°C in 1ml cold D-PBS
containing 50 l of protein G microbeads
(MACS Protein G Microbeads, MACS
Molecular, Miltenyi Biotec, France). Cells
were then washed twice in cold D-PBS and
incubated in DMEM containing 10% SVF and
kept at 4°C, or incubated for 30 minutes at
37°C. Removal of surface bound M1 antibody
was achieved by washing the cells three times
5 minutes in cold PBS containing 1mM
EDTA. A post-nuclear supernatant was
prepared in 8% sucrose supplemented in 3
mM imidazole, pH 7.4 and 2X protease
inhibitor mixture (Gruenberg et al., 1989). The
magnetic immune complex was passed over a
column placed in the magnetic field of a
MACS Separator. The labelled TNF
receptosome was retained within the column
while unbound material was washed away
with 8% sucrose, 3mM imidazole pH 7.4. The
magnetic fractions were collected by removing
the column from the magnetic field and
analysed by SDS-PAGE and Western blotting.
Solubilisation of endosomes was performed
using a solution of 8% sucrose, 3mM
imidazole, pH 7.4, containing 0.5 % Triton-
X100.
RESULTS
Alix interacts with pro-caspase-8 through
ALG-2.
In order to understand how Alix might
control cell death, we first characterised some
of the proteins interacting with it during
apoptosis. For this, we used cerebellar granule
cells, which survive in absence of serum when
cultured in high extracellular potassium (25
mM) but undergo apoptosis soon after they are
incubated in a medium containing normal
extracellular potassium concentrations (5
5mM). We previously observed that expression
of Alix-CT blocks caspase activation in
neurons deprived of potassium (17). We used
a polyclonal anti-Alix antibody to
immunoprecipitate the endogenous protein
from cell lysates made from neurons incubated
for 4 hours in 5 mM potassium. Using peptide
mass fingerprinting (see Materials and
Methods), we found caspase-8 among the
proteins co-immunoprecipitated with Alix,
suggesting that the protease may physically
associate with Alix. We further showed that in
BHK-21 cells, Flag-tagged-Alix (Flag-Alix)
and an HA-tagged-, catalytically inactive
version, of pro-caspase-8 (HA-DN-pro-
caspase-8) (Figure 1) co-immunoprecipitated.
This demonstrates that the two proteins exist
in a complex and that activity of the caspase is
not required for this interaction (Figure 2A).
Furthermore, deletion of the prodomain of
pro-caspase-8 containing the two DED
domains abolished the capacity of the caspase
to interact with Alix (Figure 2B). Addition of
1 mM Ca
2+
in the lysates strikingly enhanced
the amount of Alix co-immunoprecipitating
with pro-caspase-8 (Figure 2A) and we
detected endogenous ALG-2 in
immunoprecipitates containing overexpressed
Alix and pro-caspase-8 (Figure 2C). This
prompted us to test a potential interaction of
pro-caspase-8 with ALG-2, whose binding to
Alix depends on calcium. In the case where
ALG-2 was co expressed with DN-pro-
caspase-8, ALG-2 co-immunoprecipitated
with the caspase in presence of 1 mM CaCl2
(Figure 3A). Here again, this interaction
required the pro-domain of the caspase (Figure






binding of ALG-2 (17) (AlixALG-2) (Figure
1) did not immunoprecipitate with DN-pro-
caspase-8 (Figure 3C). On the other hand,
ALG-2 could be co-immunoprecipitated with
DN-pro-caspase-8 equally well from lysates of
wt BHK cells or from cells in which Alix
expression had been down regulated using a
pSuper vector coding for an shRNA against
Alix, indicating that ALG-2 can interact with
pro-caspase-8 independently of Alix (Figure
3D).
Alix immunoprecipitates with TNF-R1
independently of ALG-2.
The demonstration that TNF-R1 needs
endocytosis to recruit pro-caspase-8 prompted
us to test whether Alix and ALG-2 act as
adaptors bringing pro-caspase-8 into close
vicinity of endosomes containing TNF-R1.
First, we examined whether Alix and ALG-2
can form a complex with TNF-R1.
These experiments were performed in HEK
293 cells transiently transfected with
expression vectors coding for TNF-R1 and
Alix. As reported (20), TNF-R1
overexpression was sufficient to induce
apoptosis, even in absence of TNF. Western
blot analysis of Alix or TNF-R1
immunoprecipitates (Figure 4A and not
shown) revealed the presence of TNF-R1 and
Alix respectively, suggesting the existence of
a complex containing both proteins. We
further proved the existence of such a complex
by showing that endogenously expressed Alix
is pulled down with endogenous TNF-R1
immunoprecipitated from Hela cells (Figure
4B). In HEK 293 cells, TNF-R1 mutant
deleted of the death domain (TNF-R1DD)
(Figure 1) did not co-immunoprecipitate with
Alix, indicating that the interaction depends on
the integrity of this region (Figure 4C).
AlixALG-2, which does not interact with
pro-caspase-8, was capable of co-
immunoprecipitating with TNF-R1 (Figure
4C). This underscores the fact that binding of
Alix to a TNF-R1 complex is independent of
ALG-2 and of pro-caspase-8. Interestingly,
Alix mutants lacking the Bro1 domain,
required for interaction with CHMP-4B, or
four amino acids necessary for binding to
Tsg101, were not capable of co-precipitating
with TNF-R1 (Figure 4D). Thus, co-
immunoprecipitation of Alix with TNF-R1
requires its ability to bind ESCRT proteins.
ALG-2 immunoprecipitates with TNF-R1 in
a way which tightly depends on its capacity to
bind calcium.
We next asked whether ALG-2 can associate
to TNF-R1. Lysates from HEK 293 cells co-
transfected with Flag-ALG-2 and wild-type
TNF-R1 expression vectors were
immunoprecipitated with anti-Flag (Figure
5A) or with anti-TNF-R1 antibodies (not
shown). In both cases, Western blots revealed
co-immunoprecipitation of TNF-R1 with
ALG-2. Furthermore, endogenous Alix was
detected in the ALG-2 immunoprecipitates
containing TNF-R1 (Figure 5A).
We also used a mutated form of ALG-2,
ALG-2EF
1,3
, harbouring point mutations in
the first and third EF hands which abolish its
capacity to bind calcium. In accordance to
6published observations (21), this calcium
binding- deficient ALG-2 did not co-
immunoprecipitate with Alix (Figure 5Ba).
ALG-2EF
1,3
was also unable to interact with
TNF-R1, stressing the fact that ALG-2 must
be able to bind Ca
2+
in order to co-
immunoprecipitate with TNF-R1 (Figure
5Bb). These results show that even though
formation of a complex containing TNF-
R1/Alix does not necessitate interaction with
ALG-2, the latter bound to calcium can
associate with it, possibly by binding to Alix.
Alix is associated with TNF-R1
receptosomes
Our observation that deletion of ESCRT
interacting domains from Alix impairs its
capacity to bind to TNF-R1 containing
complexes, could suggest that interaction of
the protein with the TNF-R1 complex occurs
on endosomes. To examine this possibility, we
used magnetic beads coupled to protein G to
immuno-isolate TNF containing endosomes,
a method modified from that published by
Schütze and colleagues (3): Flag tagged-TNF
was applied to HEK 293 cells overexpressing
TNF-R1 at 4°C in presence of M1, an anti-
Flag antibody binding only in presence of
calcium. Cells were incubated at 37°C for 30
minutes to allow endocytosis and then treated
briefly with EDTA to remove surface bound
antibody. The resulting immuno-isolated
membrane fractions contained TNF-R1, two
markers of endosomes, EEA1 and Lamp-1,
but neither the mitochondrial marker HSP70,
nor cis-Golgi marker GM130, stressing the
endosomal origin of these fractions (Figure
6A). None of the proteins tested could be
detected in magnetic particles recovered from
cells left at 4°C and treated with EDTA
(Figure 6A, lanes 0), thus demonstrating the
efficiency of the washing procedure for
removing the M1 anti-Flag antibody from
TNF bound to TNF-R1 remaining on the cell
surface.
Triton X-100 solubilisation of the endosomal
membranes, witnessed by the loss of EEA1
and Lamp-1 labelling, left intact TNF-R1,
Alix, ALG-2, pro-caspase-8, and FADD-
immunoreactivity (Figure 6B). This result
indicates that these proteins interact within
complexes containing endocytosed TNF-R1
bound to TNF
AlixALG-2 protects HEK 293 cells from
TNF-R1 induced cell death without affecting
internalisation of the receptor.
HEK 293 cells die soon after transfection
with an expression vector coding for TNF-R1
but not with one encoding TNF-R1DD
(Figure 7Aa). Blocking clathrin-dependent
endocytosis by a dominant negative mutant of
dynamin 2a, significantly reduced TNF-R1
induced cell death (Figure 7Aa). AlixALG-2,
which interacts with TNF-R1 but not with pro-
caspase-8, inhibited cell death induced by
TNF-R1, estimated by Hoechst nuclear
staining (Figure 7Ab) and MTT-assay (Figure
7B). Alix-wt or AlixTSG101, which cannot
interact with TNF-R1, did not protect against
TNF-R1-induced cell death (Figure 7Ab).
Using [
125
I] radiolabelled TNF we found no
difference in TNF internalisation between
TNF-R1 overexpressing cells co-transfected
with control plasmid, Alix or AlixALG-2,
whereas internalisation was abolished by co-
transfection with a dominant negative mutant
of dynamin 2a (Figure 7C). These results
indicate that the protective effect of
AlixALG-2 is not due to blockade of
receptor internalisation.
AlixALG-2 blocks cell death of cervical
motoneurons which is regulated by TNF-R1.
We finally tested whether the participation of
Alix and ALG-2 in the TNF-R1 death pathway
demonstrated in vitro may also apply in vivo.
For this we searched whether programmed cell
death of cervical motoneurons (MTN) in the
chick embryo, which is efficiently blocked by
expression of AlixALG-2 (18), depends on
TNF-R1. RT-PCR analysis revealed
expression of the TNF-R1 mRNA in whole
chick embryo extracts from HH stage 16 to
HH stage 27 (Figure 8A). We next used a
polyclonal antibody, raised against the
extracellular part of human TNF-R1, which
we verified to recognize the chick counterpart
(40.5% identity on the 222 extracellular
amino-acids). Indeed, the antibody revealed
bands at the expected 55 kD in blots prepared
from chick fibroblasts (DF1 cell line) and
chick embryo extracts (Figure 8B).
Immunostaining revealed expression of TNF-
R1 in the dermomyotome but not in the neural
tube of HH stage 16 chick embryo. Labelling
of the ventral-most part of the ventral horn and
of MTN axons growing out of the tube was
detected at HH stage 21 and 24 (Figure 8C-D),
and decreased at HH stage 27 (not shown).
7Taken together, these results show that TNF-
R1 is transiently expressed in MTN during a
short period corresponding to that of
programmed cell death. In comparison, Alix is
expressed in the same areas of the neural tube
but appearing earlier (HH stage 16) and for
longer during development (22).
We first tested the involvement of caspase-8
during death of MTN, using electroporation of
the chick neural tube. This technique allows
expression of the protein of interest in one half
of the embryo, the other half being left intact
for comparison. p35, a baculovirus protein
inhibiting most caspases (23), was
electroporated into the cervical neural tube of
HH stage 16 embryos which were sacrificed
48 hours later (Figure 9Aa). Comparison
between transfected and non transfected
ventral horns of the same embryo revealed a
reduction by half of the number of TUNEL
positive neurons in the p35 expressing ventral
horn (Figure 9Ab and 9B). Using the same
technique, we found that expression of DN-
pro-caspase-8 (Figure 9Ac,d and 9B) also
reduced the number of dying neurons to a
similar degree as AlixALG-2 (18). This
indicates a role of Alix/ALG-2 and of the
death-receptor regulated apical caspase-8 in
MTN programmed cell death during
development.
Overexpression of human wild-type TNF-R1
is sufficient, like Alix overexpression, to
induce massive apoptosis throughout the
neural tube (data not shown). On the contrary,
expression of TNF-R1DD halved the number
of TUNEL positive nuclei in the ventral part
of the tube (Figure 9Ae,f and 9B). This,
together with our demonstration that the
endogenous receptor is expressed at the time
of programmed cell death, indicates that
activation of TNF-R1 regulates the death of
cervical motoneurons. Taken together, these in
vivo data strongly suggest that AlixALG-2
blocks programmed cell death by interfering
with TNF-R1 death signalling.
DISCUSSION
We previously showed that overexpressed
Alix is sufficient to activate caspases and
apoptosis and that this activity requires
binding to ALG-2. On the contrary, expression
of the C-terminal half of Alix blocked
apoptosis depending on its capacity to bind
ALG-2, suggesting that it acts by titrating out
ALG-2 (17,18). Interestingly, this truncated
form of Alix accumulates in cytoplasmic
inclusions which also contain ALG-2 and
activated caspases (17, Chatellard-Causse et
al., unpublished observations ). Rao et al. have
shown that ALG-2 is necessary for caspase
activation following an abnormal rise in
cytosolic calcium (24). Their observations
suggested that ALG-2 belongs to a complex
allowing caspase-9 activation following
cytosolic calcium elevation due to a stress to
the reticulum. Our present results demonstrate
that ALG-2 can also form a complex with pro-
caspase-8, independently of Alix, and that this
requires the prodomain of the zymogen but not
the catalytic activity of the protease.
Historically, caspase-8 was described as an
initiator caspase activated by members of the
TNF-R1 family of death receptors stimulating
the extrinsic pathway of apoptosis (25). These
latter recruit, through an 80 amino-acid long
Death Domain (DD), other DD containing
cytoplasmic proteins which participate in the
formation of the Death Inducing Signalling
Complex (DISC) recruiting and activating pro-
caspase-8 or 10. We observed that the DD of
TNF-R1 is mandatory for the interaction with
Alix and therefore with the Alix/ALG-2
complex. The TNF ligand is known to
induce, via the intracellular domain of the
receptor, the rapid formation of complex I
made of the adaptor TRADD, the protein
kinase RIP1 and the signal transducer TRAF2.
This complex signals cell survival through
JNK and IkB kinase, the latter activating
transcription factor NFkB whose targets can
mediate cell survival. Complex I can
dissociate from the receptor and, together with
the adaptor protein FADD, recruit and activate
pro-caspase-8 (26). Schütze and colleagues
introduced a twist to this model when they
published convincing data showing that
aggregation of TRADD, FADD and caspase-8
can occur on TNF-R1, but that this is critically
dependent on receptor endocytosis (3). In line
with this, we observed that blocking clathrin
dependent endocytosis significantly inhibited
apoptosis induced by TNF-R1. In their model,
Schneider-Brachert et al. claim that TNF-R1
containing endosomes would establish the
platform on which the DISC may form (3).
Since Alix can bind TNF-R1, on one side, and
ALG-2 which can interact with caspase-8 on
the other, it may act as an adaptor for
recruiting pro-caspase-8 on the surface of
8TNF-R1 containing endosomes. In favour of
this model, we found that binding of Alix to
TNF-R1 is totally abolished upon deletion of
its binding domains to CHMP-4B and Tsg-101
of ESCRT-III and ESCRT-I respectively,
suggesting that stabilisation of Alix binding to
the TNF-R1 complex occurs through
interactions with these endosomal proteins.
Furthermore we could identify TNF-R1, Alix,
ALG-2, caspase-8, and FADD within a
common, Triton-X100 resistant, complex in
endosomal fractions containing TNF bound
to its endocytosed receptor. Thus AlixALG-2
may block death induced by TNF-R1 by
impairing the recruitment of pro-caspase-8
onto surface of TNF-R1 containing
endosomes. The protecting effect of
AlixALG-2 is not simply due to blocking of
endocytosis of the activated receptor, as this is
not influenced by the mutant. Nor is it due to
an impairment of the degradation of the
receptor inside lysosomes since the dead
version of the ATPase SKD-1, which leads to
gross abnormalities in multivesicular
endosomes (27), had no protecting activity
against TNF-R1.
In order to verify that Alix/ALG-2 may
regulate TNF-R1 induced cell death in a
physiological setting, we extended our
previous studies showing that AlixLG-2
can block the programmed cell death (PCD) of
chick cervical MTN (18) by demonstrating
that this phenomenon is driven by TNF-R1.
Among death receptors of the TNF-R family,
P75
NGFR
, Fas, and TNF-R1 (28) have been
postulated to play an active role during MTN
developmental death. Sedel et al. have shown
that death of E12-13 rat MTN is regulated by
TNF and that death of mouse MTN is
significantly reduced in double KO for TNF
and TNF-R1(29). In the chick embryo, TNF
was detected by imunohistochemistry from
HH stage 18 (E3) with a peak at HH stage 24
to 25 (E4.5 to E5) (30) and we found that
TNF-R1 is transiently expressed during PCD
of cervical MTN with a pattern reminiscent of
that of Alix. Our demonstration that TNF-
R1DD impaired death of cervical MTN, in a
way similar to the pan caspase inhibitor p35,
DN-pro-caspase-8 or AlixALG-2 (18),
demonstrates that TNF-R1 drives MTN PCD
which is regulated by Alix/ALG-2. It is here
noteworthy that CIN85, another interactor of
Alix, has been reported to be involved in TNF-
R1 signalling (31) and we have observed that
deletion of the CIN85 binding site impairs the
death blocking activity of the C-terminal half
of Alix in chick MTN (Mahul-Mellier,
unpublished observation).
de Gassart et al. have reported caspase
activity in exosomes, which correspond to
intralumenal vesicles of MVBs and are
enriched in Alix (32). Exosomes also bear
TNF-R1 indicating that the receptor is a cargo
of the intralumenal vesicles, but without its
interactors TRADD, RIP and TRAF2 (33). It
may therefore be speculated that Alix and
ALG-2 which accompany and get entrapped
into vesicles budding inside MVBs could pull
TNF-R1 and caspase-8 inside endosomes.
This would efficiently isolate the activated
caspase from its cytosolic substrates and lead
to its rapid degradation inside lysosomes
fusing with MVBs. Thus, one reason for why
activation of pro-caspase-8 in the vicinity of
Alix and ALG-2 occurs on the surface of
endosomes containing TNF-R1 is that it may
allow a potent control, to rapidly tune down
caspase-8 activity.
As ALG-2 binding to Alix is strictly
calcium-dependent, our results also beg the
question of the relationship between cytosolic
calcium and TNF-R1. The present literature
remains controversial about the role of
cytosolic calcium in TNF induced cell death.
Some investigators have failed to find
evidence for a TNF induced calcium
response in U937 monocytes (34) or in KYM-
1 and Hela cells overexpressing the TNF
receptor (35). In contrast, Bellomo et al. (36)
and Kong et al (37) found an increase in
intracellular calcium using BT-20 and L929
cells, respectively. More recently, Draper et
al. (38) found a sustained rise in cytosolic
calcium following CHX/ TNF treatment of
C3HA fibroblast cells. Fas, which also
requires endocytosis for caspase-8 activation,
has been shown to induce calcium release
from internal stores. It is also noteworthy that
endosomes are known to contain high
concentrations of calcium and calcium leakage
from endosomes regulates their maturation
(39). Thus a rise in calcium in the close
vicinity of endosomes might allow ALG-2 to
bind to Alix and recruit caspase-8 on the
surface of endosomes. This is even more
relevant knowing that Fas-mediated apoptosis
requires calcium release from the endoplasmic
reticulum (40) and we will now test whether
9Fas-mediated cell death, also involves
Alix/ALG-2 during activation of caspase-8.
We will also need to examine whether the
interaction of ALG-2 and Alix to pro-caspase-
8 and TNF-R1, respectively, is direct or
through proteins of the DISC complex.
Interactions within this complex are
homophilic between DD or Death Effector
Domains (DED). We showed that the DD of
TNF-R1 and the DED containing pro-domain
of pro-caspase 8 are obligatory for binding to
Alix and ALG-2 respectively, and that FADD
is present in the Alix/ALG-2/pro-caspase-8
complex. Since apparently, neither Alix nor
ALG-2 contain death adaptor domains, we
now need to characterize the new module
which allows their interaction to the DISC.
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FIGURE LEGENDS
Fig. 1: Schematic representation of Alix pro-caspase-8 and TNF-R1 and their mutants used
throughout this study
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Fig. 2: Alix co-immunoprecipitates with DN-pro-caspase-8.
A. Alix/pro-caspase-8 co-immunoprecipitation (IP) requires calcium.
BHK cells co-expressing Flag-Alix and HA-DN-pro-caspase-8 were lysed and
immunoprecipitated with anti-HA antibody in RIPA buffer supplemented or not with 1 mM
CaCl2. Immunoprecipitates were blotted and analysed with polyclonal antibodies agains Alix
(lower) and against HA (upper panel).
B. Co-IP of Alix with DN-pro-caspase-8 requires the pro-domain of the zymogen.
BHK cells co-expressing Flag-Alix together with HA-DN-pro-caspase-8 or HA-DN-caspase-
8-DED were lysed and immunoprecipitated with anti-HA in RIPA containing 1 mM CaCl2
(CaRIPA) and analysed as in A.
C. Endogenous ALG-2 is detected in pro-caspase-8/ Alix co-immunoprecipitates.
BHK cells co-expressing Flag-Alix together with HA-DN-pro-caspase-8 were lysed and
immunoprecipitated as in B; immunoprecipitates were analysed by Western Blot (WB) with
polyclonal anti HA , anti-ALG-2 and anti-Flag antibodies (from top to bottom).
Fig. 3: ALG-2 co-immunoprecipitates with DN-pro-caspase-8.
A. ALG-2/pro-caspase-8 co-IP requires calcium.
BHK cells co-expressing Flag-ALG-2 and HA-DN-pro-caspase-8 were lysed and
immunoprecipitated with anti HA in RIPA (), or RIPA containing either 3 mM EGTA or 1
mM CaCl2. Immunoprecipitates were analysed using polyclonal antibodies against HA (upper)
and Flag (lower panel).
B. Co-IP of ALG-2 with DN-pro-caspase-8 requires the pro-domain of the zymogen.
BHK cells co-expressing Flag-ALG-2 together with HA-DN-pro-caspase-8 or HA-DN-
caspase-8-DED were lysed and immunoprecipitated with anti HA in CaRIPA and analysed
as in A.
C. Co-IP of Alix with DN-pro-caspase-8 requires its ALG-2 binding domain.
BHK cells were co-transfected with either Flag-Alix WT or Flag-AlixALG-2 and HA-DN-
pro-caspase-8. IP with anti-HA antibody were performed in CaRIPA. Immunoprecipitates
were analysed by WB using polyclonal antibodies against HA (upper) and Alix (lower panel).
D. ALG-2 co-immunoprecipitates with DN-pro-caspase-8 in cells depleted of Alix.
BHK cells expressing shAlix to down-regulate expression of the protein were transfected with
Flag-ALG-2 and HA-DN-pro-caspase-8 lysed in CaRIPA and immunoprecipitated with an
anti-HA antibody. Immunoprecipitates were analysed by WB using anti-Flag (lower) and HA
polyclonal antibodies (upper panel). Right insert: Western blot analysis of lysates using a
polyclonal antibody anti-Alix and a monoclonal anti-actin shows the decrease of endogenous
Alix expression in BHK shAlix cells.
Fig. 4: Alix co-immunoprecipitates with TNF-R1.
A. Co-IP of overexpressed Alix and TNF-R1. RIPA lysates of HEK 293 cells co-expressing
Flag-Alix and TNF-R1 were immunoprecipitated with anti-Flag antibodies and blots probed
with anti-Alix (upper) and anti-TNF-R1 (lower panel).
B. Co-IP of endogenous Alix and TNF-R1.
RIPA lysates of Hela cells were immunoprecipitated using a polyclonal anti-TNF-R1. The IP
was analysed by WB using a monoclonal antibody against human Alix.
C. Co-IP of Alix with TNF-R1 requires the death domain of the receptor.
RIPA lysates of HEK 293 cells co-expressing Flag-Alix and TNF-R1 deleted from its death
domain (TNF-R1DD) were immunoprecipitated with anti-Flag or with anti-TNF-R1 and
blots probed with the appropriate polyclonal antibodies as in A
D. Co-immunoprecipitation of Alix with TNF-R1 requires its binding site to Tsg101 and Bro1
but not to ALG-2.
Cells co-expressing TNF-R1 and either Flag-AlixTsg101, Flag-AlixBro1 or Flag-
AlixALG-2 were solubilised in RIPA and total lysates immunoprecipitated with anti-Flag;
Western blots were probed with the appropriate polyclonal antibodies as in A and C.
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Fig. 5: ALG-2 co-IP with TNF-R1 requires its capacity to bind calcium.
A. ALG-2 co-IP with TNF-R1 and Alix. HEK293 cells were co-transfected with Flag-ALG-2
and TNF-R1. RIPA cell lysates were immunoprecipitated with anti-Flag or with anti-TNF-R1
and blots probed with the appropriate antibodies. Lower panel shows the presence of
endogenous Alix within the immunoprecipitates as revealed with an anti-Alix antibody.
B. Calcium binding-deficient ALG-2 mutant does not co-IP with Alix (a) or with TNF-R1 (b).
HEK293 co-expressing Flag-Alix a) or TNF-R1 b) together with Flag-ALG-2EF
1,3
, a point
mutant unable to bind Ca
2+
, were solubilised and immunoprecipitated in CaRIPA; Western
blots were probed with the appropriate polyclonal antibodies.
Fig. 6: Alix and ALG-2 are present with pro-caspase-8 and FADD on TNF receptosomes.
A. Western blot analysis of Flag-TNF containing endosomes prepared from HEK 293, over-
expressing TNF-R1 and Myc-Alix.
0: Cells maintained at 4°C were washed with EDTA prior to endosome preparation. 30: cells
incubated for 30 minutes at 37°C to induce endocytosis of TNF bound to TNF-R1 before
lysis. Magnet-isolated endosomes were run on SDS PAGE and immuno-blotted to reveal the
presence of EEA1 (early endosomes), LAMP1 (late endosomes and lysosomes), GM130 (cis-
Golgi) or HSP70 (mitochondria).
B. Solubilisation of TNF-R1 receptosomes leaves intact a complex containing Alix, ALG-2,
FADD and pro-caspase-8.
TNF-R1 receptosomes prepared as in A were solubilised on the affinity column using 0.5 %
Triton-X100 and analysed by Western blotting using the appropriate antibodies. The lack of
EEA1 and LAMP1 confirms membrane solubilisation of TNF receptosomes.
Fig. 7: AlixALG-2 protects HEK293 from TNF-R1-induced cell death without impairing
internalisation of the receptor.
A. TNF-R1 overexpression triggers apoptosis which is inhibited by AlixALG-2 but not by
AlixTsg101 or SKD1 DN.
a-b: HEK 293 cells transfected with expression vectors coding for RFP or TNF-R1 and the
indicated proteins. Viability was scored on the basis of nuclear morphology; cells with
condensed or fragmented nuclei were counted as dead. Values are the means +/- SD of dying
cells from three independent experiments. **t test, p<0.001.
B. MTT metabolic colorimetric test confirms the protective effect of AlixALG-2. Each value
represents the mean +/- SD of triplicate wells from three independent experiments. **t test,
p<0.001.
C. TNF-R1/TNF internalisation is impaired by a dominant negative form of dynamin but not
by Alix or AlixALG-2.
TNF-R1 internalisation was analysed using [
125
I]-TNF in TNF-R1 expressing cells. Each
point represents the mean +/- SD of triplicate wells from three independent experiments. **t
test, p<0.001.
Fig. 8: TNF-R1 is expressed during chick neural tube development.
A. RT-PCR analysis shows gene expression in whole extracts from chick embryos from HH
stage 16 to HH stage 27.
B. Polyclonal anti-TNF-R1 recognises a main band at 55 kDa in HEK cells and a doublet with
the lower band corresponding to 55 kDa in DF1 chick fibroblasts. A similar pattern is
observed in chick embryo extracts (21HH, 24HH).
C-D. Cross sections of HH stage 21 (C) or 24 (D) chick embryo neural tubes immunostained
with polyclonal anti-TNF-R1. Scale bar = 50 m.
Fig. 9: TNF-R1 is involved in early cell death of cervical motoneurons.
A: Cross sections of HH stage 24 chick embryo neural tubes electroporated with pCAGGS
expression vectors coding for: (a, b) GFP-p35; (c, d) DN-pro-caspase-8; (e, f) TNFR1DD-
13
YFP; a, c, e: GFP expression 48 h after electroporation. b, d, f: TUNEL labelling of adjacent
sections. Scale bar = 50 m.
B: Ratio of TUNEL-positive cells in the electroporated versus non-electroporated side of the
neural tube. Mean numbers +/- SD of TUNEL-positive cells in the neural tube of
electroporated embryos, n= number of sections analysed; twelve sections per embryo were
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